These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 21167409

  • 1. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
    Felcht M, Booken N, Stroebel P, Goerdt S, Klemke CD.
    J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
    [Abstract] [Full Text] [Related]

  • 2. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, Canninga-van Dijk MR, Geerts ML, Hebeda KM, Kluin PM, Lam KH, Meijer CJ, Willemze R.
    J Clin Oncol; 2007 Apr 20; 25(12):1581-7. PubMed ID: 17353548
    [Abstract] [Full Text] [Related]

  • 3. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
    Koens L, Vermeer MH, Willemze R, Jansen PM.
    Am J Surg Pathol; 2010 Jul 20; 34(7):1043-8. PubMed ID: 20551823
    [Abstract] [Full Text] [Related]

  • 4. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ, Willemze R.
    Br J Dermatol; 2007 Dec 20; 157(6):1205-11. PubMed ID: 17941944
    [Abstract] [Full Text] [Related]

  • 5. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
    Mao X, Orchard G.
    Br J Dermatol; 2008 Jul 20; 159(1):145-51. PubMed ID: 18460027
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
    Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P.
    Exp Dermatol; 2011 Apr 20; 20(4):331-5. PubMed ID: 21410763
    [Abstract] [Full Text] [Related]

  • 7. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL.
    J Am Acad Dermatol; 2013 Sep 20; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T.
    Arch Dermatol; 2007 Sep 20; 143(9):1144-50. PubMed ID: 17875875
    [Abstract] [Full Text] [Related]

  • 11. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
    Felcht M, Heck M, Weiss C, Becker JC, Dippel E, Müller CS, Nashan D, Sachse MM, Nicolay JP, Booken N, Goerdt S, Klemke CD.
    Br J Dermatol; 2012 Aug 20; 167(2):348-58. PubMed ID: 22512270
    [Abstract] [Full Text] [Related]

  • 12. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B, Tyler K, Gru AA, Winardi FK, Frederickson J, Hastings J, Elkins C, Zhang X, Xu-Welliver M, Wong HK, Porcu P.
    Oncologist; 2015 Oct 20; 20(10):1161-6. PubMed ID: 26306900
    [Abstract] [Full Text] [Related]

  • 13. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M, Lucioni M, Maffi A, Croci GA, Nicola M, Berti E.
    G Ital Dermatol Venereol; 2012 Dec 20; 147(6):589-602. PubMed ID: 23149705
    [Abstract] [Full Text] [Related]

  • 14. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R, Dutch Cutaneous Lymphoma Group.
    Arch Dermatol; 2007 Dec 20; 143(12):1520-6. PubMed ID: 18087001
    [Abstract] [Full Text] [Related]

  • 15. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
    Giménez S, Costa C, Espinet B, Solé F, Pujol RM, Puigdecanet E, García-Moreno P, Sánchez J, Gallardo F, Estrach T, García-Muret P, Romagosa V, Serrano S, Servitje O.
    Exp Dermatol; 2005 Dec 20; 14(12):883-90. PubMed ID: 16274455
    [Abstract] [Full Text] [Related]

  • 16. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry.
    Smith BD, Smith GL, Cooper DL, Wilson LD.
    J Clin Oncol; 2005 May 20; 23(15):3390-5. PubMed ID: 15908651
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
    Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S, Santucci M, Bernengo MG, Italian Study Group for Cutaneous Lymphomas.
    J Clin Oncol; 2006 Mar 20; 24(9):1376-82. PubMed ID: 16492713
    [Abstract] [Full Text] [Related]

  • 18. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
    Hallermann C, Niermann C, Fischer RJ, Schulze HJ.
    Acta Derm Venereol; 2011 Sep 20; 91(5):521-5. PubMed ID: 21547335
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
    Kempf W, Kazakov DV, Mitteldorf C.
    Am J Dermatopathol; 2014 Mar 20; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
    [Abstract] [Full Text] [Related]

  • 20. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL, Querfeld C, Horwitz S, Pulitzer M, Moskowitz A, Myskowski PL.
    J Am Acad Dermatol; 2013 Sep 20; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.